113 related articles for article (PubMed ID: 9132646)
1. Pefloxacin in adriamycin induced nephrotic syndrome in the rat.
Korzets Z; Pomeranz A; Golan E; Bernheim J
Nephrol Dial Transplant; 1997 Feb; 12(2):286-8. PubMed ID: 9132646
[TBL] [Abstract][Full Text] [Related]
2. [The effect of pefloxacin on nephrotic syndrome in experimental adriamycin nephropathy].
Zima T; Tesar V; Rychlík I; Nĕmecek K; Poledne R; Stejskalová A; Tĕmínová J; Stípek S; Merta M
Cas Lek Cesk; 1995 Oct; 134(20):658-60. PubMed ID: 7489582
[TBL] [Abstract][Full Text] [Related]
3. The influence of pefloxacine on experimental adriamycin-induced nephrotic syndrome in rats.
Zima T; Tesar V; Rychlík I; Nĕmecek K; Poledne R; Tĕmínová J; Stípek S; Merta M
Ren Fail; 1996 Mar; 18(2):195-9. PubMed ID: 8723357
[TBL] [Abstract][Full Text] [Related]
4. Protection by Chinese herbs against Doxorubicin-induced focal and segmental glomerulosclerosis in rats.
Tong Y; Wang Q; Hou H
Drug Dev Ind Pharm; 2008 Jul; 34(7):663-7. PubMed ID: 18608470
[TBL] [Abstract][Full Text] [Related]
5. [The effect of chronic administration of ethanol on experimental adriamycin nephropathy].
Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
Cas Lek Cesk; 1994 May; 133(9):268-71. PubMed ID: 8194094
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of deferoxamine, N-acetylcysteine and selenium treatments in rats with Adriamycin-induced nephrotic syndrome.
Bulucu F; Oktenli C; Kenar L; Ocal R; Koc B; Inal V; Yamanel L; Yaman H; Sanisoglu YS; Aydin A
J Nephrol; 2008; 21(4):576-83. PubMed ID: 18651549
[TBL] [Abstract][Full Text] [Related]
7. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
Tesar V; Zima T; Jirsa M; Crkovská J; Stípek S; Vernerová Z; Seráková M
Cas Lek Cesk; 1999 Oct; 138(18):560-4. PubMed ID: 10596472
[TBL] [Abstract][Full Text] [Related]
8. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
9. Pefloxacin as first-line treatment in nephrotic syndrome.
Ginsburg C; Toledano D; Deray G; Vlassopoulos D; Baumelou A; Jacobs C
Nephrol Dial Transplant; 1994; 9(3):335. PubMed ID: 8052452
[No Abstract] [Full Text] [Related]
10. NAC attenuates adriamycin-induced nephrotic syndrome in rats through regulating TLR4 signaling pathway.
Yao H; Cai ZY; Sheng ZX
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1938-1943. PubMed ID: 28485782
[TBL] [Abstract][Full Text] [Related]
11. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
[TBL] [Abstract][Full Text] [Related]
12. Early treatment with everolimus exerts nephroprotective effect in rats with adriamycin-induced nephrotic syndrome.
Ramadan R; Faour D; Awad H; Khateeb E; Cohen R; Yahia A; Torgovicky R; Cohen R; Lazari D; Kawachi H; Abassi Z
Nephrol Dial Transplant; 2012 Jun; 27(6):2231-41. PubMed ID: 22036940
[TBL] [Abstract][Full Text] [Related]
13. Effect of pefloxacin on experimental adriamycin-induced nephrotic syndrome.
Zima T; Tesar V; Rychlík I; Nĕmecek K; Poledne R; Témínová J; Stípek S; Merta M
Nephrol Dial Transplant; 1995; 10(8):1472. PubMed ID: 8538951
[No Abstract] [Full Text] [Related]
14. Pseudoductules in the rat liver in experimental adriamycin-induced nephrotic syndrome.
Pedrycz A; Wieczorski M; Czerny K
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):154-60. PubMed ID: 12898918
[TBL] [Abstract][Full Text] [Related]
15. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
[TBL] [Abstract][Full Text] [Related]
16. ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats.
Zima T; Tesar V; Crkovská J; Stejskalová A; Pláteník J; Temínová J; Nemecek K; Janebová M; Stípek S
Nephrol Dial Transplant; 1998 Aug; 13(8):1975-9. PubMed ID: 9719150
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of glycyrrhizin on nephrotic syndrome induced by adriamycin in rats.
Bi X; Zhu G; Han Z; Ye Y; Liang Y; Zhang L; Hao Z; Zeng G; He H; Zhong W
Clin Invest Med; 2009 Jun; 32(3):E229-38. PubMed ID: 19480741
[TBL] [Abstract][Full Text] [Related]
18. The influence of chronic ethanol administration on adriamycin-induced nephrotic syndrome in rats.
Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
Alcohol Alcohol; 1995 Jan; 30(1):47-53. PubMed ID: 7748275
[TBL] [Abstract][Full Text] [Related]
19. [Pefloxacin as a first-line treatment for nephrotic syndrome in minimal glomerular lesions in the adult. Multicenter study of 32 patients].
Pruna A; Barka A; Nochy D; Hauet T; Boulanger H; Landais P
Nephrologie; 1997; 18(3):95-101. PubMed ID: 9297136
[TBL] [Abstract][Full Text] [Related]
20. The progression of adriamycin-induced nephrotic syndrome in rats and the effect of captopril.
Hall RL; Wilke WL; Fettman MJ
Toxicol Appl Pharmacol; 1986 Jan; 82(1):164-74. PubMed ID: 3511565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
